Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cholangiocarcinoma × camrelizumab × Clear all

Phase

Status

Unknown 2 Recruiting 1 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 6 Esophageal Neoplasms 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Advanced Gastric Cancer 2 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Neoplasms by Site 1 Mouth Neoplasms 1 Lung Diseases 1 Liver Diseases 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Gestational Trophoblastic Disease 1 Gastrointestinal Neoplasms 1 Esophageal Diseases 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

Gemcitabine 34 Cisplatin 20 Oxaliplatin 14 pembrolizumab 11 Capecitabine 11 Fluorouracil 8 Leucovorin 7 Radiofrequency Ablation 6 lenvatinib 5 Panitumumab 5 Bevacizumab 5 Albumin-Bound Paclitaxel 5 durvalumab 4 Nivolumab 4 Irinotecan 4 130-nm albumin-bound paclitaxel 4 tremelimumab 3 Taxes 3 Injections 3 Hepatectomy 3 Drug Therapy 3 trametinib 2 spartalizumab 2 sintilimab 2 pemigatinib 2 derazantinib 2 budigalimab 2 atezolizumab 2 apatinib 2 Stents 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04642664 2021-06-03

ACABC

Peking Union Medical College Hospital

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡